The percentage of both abnormal Anti TG‐Ab, and Anti TPO‐Ab of males with MS was higher than the control group but the differences observed were not statistically significant (p = 0.73, p = 0.54 respectively). This evidence concerns the gene TPO and myeloid sarcoma.